April 21, 2020
United States Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, DC 20549
Attention: | Jeffrey Gabor Celeste Murphy Ibolya Ignat Kevin Vaughn |
Re: | ORIC Pharmaceuticals, Inc. |
Registration Statement on Form S-1 (File No. 333-236792)
Ladies and Gentlemen:
Pursuant to Rule 460 of the General Rules and Regulations under the Securities Act of 1933, as amended, we wish to advise that between April 20, 2020 and the date hereof, approximately 425 copies of the Preliminary Prospectus dated April 20, 2020 were distributed to prospective underwriters, institutional investors and prospective dealers in connection with the above-captioned Registration Statement.
We wish to advise you that the participating underwriters have informed us that they have complied and will continue to comply with the requirements of Rule 15c2-8 under the Securities Exchange Act of 1934, as amended.
We hereby join in the request of the registrant that the effectiveness of the above-captioned Registration Statement, as amended, be accelerated to 4:00 p.m. Eastern Time, on April 23, 2020 or as soon thereafter as practicable.
[Signature page follows]
Very truly yours,
J.P. MORGAN SECURITIES LLC
CITIGROUP GLOBAL MARKETS INC.
JEFFERIES LLC
As representatives of the Underwriters
By: | J.P. Morgan Securities LLC | |
By: | /s/ Benjamin Burdett | |
Name: Benjamin Burdett | ||
Title: Managing Director |
By: | Citigroup Global Markets Inc. |
|
By: | /s/ Bradley Wolff | |
Name: Bradley Wolff | ||
Title: Managing Director |
By: | Jefferies LLC |
|
By: | /s/ Michael Brinkman | |
Name: Michael Brinkman | ||
Title: Managing Director |